COMMUNIQUÉ DE PRESSE

COVID-19 Business continuity plan

Considering the recent evolution of the COVID-19 situation, HalioDx has actioned a business continuity plan aimed at safeguarding our employees while maintaining our production and service capacity in our 2 CLIA certified laboratories in Marseille, France & Richmond, USA.

Major actions have been taken :

  • Travel restrictions
  • Health and safety instructions for all employees and our partners
  • IT system allowing remote work
  • Communication plan

The majority of employees work remotely and continue to support our customers on a daily basis. Some of our experienced laboratory teams are working on site to ensure the continuation of the wet lab operations.

Both of our FR and US sites are currently open and as an absolute priority, we will be continuing to run clinical testing and our client projects with a minimum of disruption by processing all the samples received in our laboratories. Stringent Health measures on site have been implemented, to ensure safety and well-being of our colleagues.

Should we experience any delays that impact our customers we will be contacting those affected directly. If you have any concerns regarding ongoing projects or if you want to set up an appointment with our teams, please contact us at infos(arobase)haliodx(point)com or via our contact form.

Stay safe and thank you for your confidence in HalioDx Services and Solutions.